M&A in the Chemical Industry

Navigating Uncertainty While Unlocking Strategic Opportunities

Wolfgang Kazmierowski and Christian Dehm, DC Advisory

M&A activities in the chemical industry are on the rise again, and companies with a clear strategy and consistent action will be particularly successful in the future.
© gothong_1984 - stock.adobe.com

Mergers and acquisitions (M&A) are both a driver and a reflection of consolidation in the chemical industry. They allow companies to adapt to a challenging environment, leverage synergies and strengthen their market position. Consolidation in the industry will continue, particularly in segments with persistent margin pressure, but also where investors can benefit from long-term trends such as sustainability and innovation.

The global chemical M&A market is facing a period of significant complexity. Investor confidence has been unsettled by a mix of geopolitical tensions, inflation, and regulatory shifts, creating a cautious environment for dealmaking. While general market sentiment remains mixed, we believe both investors and sellers are active in principle. 

Financial sponsors with dry powder are scanning the market for the right opportunities, while several large chemical groups are preparing to divest non-core assets as part of broader portfolio restructuring.

Read more with free registration

Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.

Sign in or register

Company

Logo:

DCAT - Drug, Chemical & Associated Technologies Association

One Union St., Suite 208
Robbinsville
US

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.